JR Keller

3.1k total citations · 1 hit paper
42 papers, 2.7k citations indexed

About

JR Keller is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, JR Keller has authored 42 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 22 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in JR Keller's work include Hematopoietic Stem Cell Transplantation (23 papers), Immune Response and Inflammation (12 papers) and TGF-β signaling in diseases (10 papers). JR Keller is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Immune Response and Inflammation (12 papers) and TGF-β signaling in diseases (10 papers). JR Keller collaborates with scholars based in United States, India and Canada. JR Keller's co-authors include FW Ruscetti, J N Ihle, E W Palaszynski, Florian Klein, LR Ellingsworth, GK Sing, M B Prystowsky, JW Schrader, L. Omar Henderson and T D Copeland and has published in prestigious journals such as Blood, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

JR Keller

42 papers receiving 2.5k citations

Hit Papers

Biologic properties of homogeneous interleukin 3. I. Demo... 1983 2026 1997 2011 1983 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JR Keller United States 23 1.3k 981 890 603 399 42 2.7k
FW Ruscetti United States 27 1.3k 1.0× 869 0.9× 969 1.1× 615 1.0× 267 0.7× 65 2.7k
H E Broxmeyer United States 26 1.5k 1.2× 2.0k 2.0× 940 1.1× 974 1.6× 407 1.0× 47 3.9k
Fawzia Louache France 37 1.3k 1.0× 1.6k 1.7× 1.0k 1.2× 827 1.4× 419 1.1× 92 3.8k
K Kaushansky United States 18 715 0.6× 919 0.9× 663 0.7× 394 0.7× 141 0.4× 24 2.2k
MA Vadas Australia 22 1.1k 0.8× 415 0.4× 433 0.5× 431 0.7× 210 0.5× 38 1.9k
F W Ruscetti United States 17 982 0.8× 559 0.6× 685 0.8× 475 0.8× 134 0.3× 33 2.0k
Mitsujiro Osawa Japan 19 892 0.7× 633 0.6× 1.8k 2.0× 1.3k 2.1× 268 0.7× 31 3.7k
V. Koneti Rao United States 27 1.7k 1.4× 409 0.4× 709 0.8× 522 0.9× 462 1.2× 87 2.8k
DA Williams United States 16 599 0.5× 460 0.5× 575 0.6× 444 0.7× 366 0.9× 37 1.5k
Sarah E. Bell United Kingdom 21 1.5k 1.1× 366 0.4× 1.3k 1.4× 345 0.6× 143 0.4× 29 2.9k

Countries citing papers authored by JR Keller

Since Specialization
Citations

This map shows the geographic impact of JR Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JR Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JR Keller more than expected).

Fields of papers citing papers by JR Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JR Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JR Keller. The network helps show where JR Keller may publish in the future.

Co-authorship network of co-authors of JR Keller

This figure shows the co-authorship network connecting the top 25 collaborators of JR Keller. A scholar is included among the top collaborators of JR Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JR Keller. JR Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keller, JR, M. Ortiz, & FW Ruscetti. (1995). Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood. 86(5). 1757–1764. 106 indexed citations
6.
Ruscetti, FW, et al.. (1994). Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor. Blood. 84(1). 125–132. 28 indexed citations
8.
9.
Ott, David E., et al.. (1992). Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences. Journal of Virology. 66(10). 6107–6116. 37 indexed citations
10.
Hestdal, Kjetil, Sten Eirik W. Jacobsen, FW Ruscetti, et al.. (1992). In vivo effect of interleukin-1 alpha on hematopoiesis: role of colony- stimulating factor receptor modulation. Blood. 80(10). 2486–2494. 24 indexed citations
11.
Hestdal, Kjetil, Sten Eirik W. Jacobsen, FW Ruscetti, et al.. (1992). In vivo effect of interleukin-1 alpha on hematopoiesis: role of colony- stimulating factor receptor modulation. Blood. 80(10). 2486–2494. 1 indexed citations
12.
Kmiecik, Thomas E., JR Keller, E M Rosen, & G Vande Woude. (1992). Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood. 80(10). 2454–2457. 11 indexed citations
15.
Jansen, Robert S., Giovanna Damia, Noriko Usui, et al.. (1991). Effects of recombinant transforming growth factor-β1 on hematologic recovery after treatment of mice with 5-fluorouracil. The Journal of Immunology. 147(10). 3342–3347. 13 indexed citations
17.
Keller, JR, et al.. (1990). Epstein-Barr virus transformed B lymphocytes produce interleukin-5. Blood. 75(7). 1400–1403. 54 indexed citations
18.
Sing, GK, JR Keller, LR Ellingsworth, & FW Ruscetti. (1988). Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood. 72(5). 1504–1511. 195 indexed citations
19.
Rein, A, et al.. (1985). Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3.. Molecular and Cellular Biology. 5(9). 2257–2264. 35 indexed citations
20.
Ihle, J N, et al.. (1982). Phenotypic characteristics of cell lines requiring interleukin 3 for growth.. The Journal of Immunology. 129(4). 1377–1383. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026